Skip to main content
. 2017;18(8):2299–2308. doi: 10.22034/APJCP.2017.18.8.2299

Figure 2.

Figure 2

Immunohistochemical Expression of TGM2 in Meningioma; A and B high TGM2 expression in malignant meningiomax400, C, High TGM2 expression in atypical meningiomax400, D, low TGM2 expression in benign meningioma